SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001370053-18-000013
Filing Date
2018-03-05
Accepted
2018-03-05 16:22:50
Documents
2
Period of Report
2018-03-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K anab-123117x8k.htm 8-K 22679
2 EXHIBIT 99.1 q417earningsrelease.htm EX-99.1 141598
  Complete submission text file 0001370053-18-000013.txt   165659
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO INC (Filer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37985 | Film No.: 18666336
SIC: 2834 Pharmaceutical Preparations